T. Naganuma et al., Regulation of noradrenaline release by S-nitroso-cysteine: inhibition in PC12 cells in a cyclic GMP independent manner, EUR J PHARM, 361(2-3), 1998, pp. 277-283
Nitric oxide (NO), including NO free radicals (. NO) and peroxynitrite (OON
O-), modulates the release of neurotransmitters from neuronal tissues. Alth
ough we reported that S-nitroso-cysteine stimulated noradrenaline release i
n brain slices, we now show that only S-nitroso-cysteine inhibits noradrena
line release from PC12 cells. S-Nitroso-cysteine inhibited, in a dose-depen
dent manner (up to 0.6 mM), the Ca2+-dependent [H-3]noradrenaline release i
nduced by ionomycin, adenosine 5'-O-(3-thiotriphosphate), or high K+, from
PC12 cells labeled with [H-3]noradrenaline. Sodium nitroprusside, S-nitroso
-N-acetylpenicillamine, and 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazen
e, which specifically release NO free radicals in neutral buffer, had minim
al effects on [H-3]noradrenaline release, although they markedly stimulated
cyclic GMP accumulation. 3-Morpholinosydonimine, which releases peroxynitr
ite, had no effect on either [H-3]noradrenaline release or cyclic GMP accum
ulation. S-Nitroso-cysteine inhibited phorbol 12-myristate 13-acetate- and
mastoparan (wasp venom toxin)-induced [H-3]noradrenaline release. These fin
dings suggest that 1) S-nitroso-cysteine, but not other NO donors, inhibits
some common process occurring during noradrenaline release in PC12 cells,
2) neither NO radicals, peroxynitrite, nor cyclic GMP mediate the inhibitor
y effects of S-nitroso-cysteine in PC12 cells. (C) 1998 Elsevier Science B.
V. All rights reserved.